ACSS3 is a metabolic enzyme in charge of catalyzing the synthesis of acetyl coenzyme A from short-chain fatty acids, which corresponds with the progression of gastric [49], hepatocellular [50], bladder [51], and prostate cancers [52]. This evidence concerns the gene ACSS3 and Familial prostate cancer.